TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
TRDA

Entrada Therapeutics Inc

Healthcare · Biotechnology · —

6.20$ +1.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Entrada Therapeutics Inc (TRDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 299 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TRDA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
485 469 511 582 555 526 486 449 413 377 336 299
383 370 414 490 465 440 403 369 338 306 267 233
52 68 68 185 78 101 68 72 93 90 76 99
354 352 327 470 449 420 383 354 327 296 255 223
5.0 5.9 78 7.7 2.6 3.7 2.0 1.2 3.2 1.2 2.3 0.8
-5.0 0.0 0.0 – -3.8 – – – – – – –
238 227 241 152 132 98 69 69 72 71 65 65
165 159 174 86 71 39 18 20 24 24 19 21
6.6 7.9 8.3 8.6 7.7 7.6 6.5 5.5 4.4 4.1 4.3 4.4
0.8 3.3 2.5 1.6 1.3 4.3 2.2 1.9 3.2 2.3 2.9 3.7
247 242 269 430 422 429 417 380 341 306 271 233
-185 -195 -171 -116 -130 -129 -147 -190 -234 -273 -313 -356
35 33 35 36 41 43 41 41 41 41 42 42

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?